The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global insulin storage devices market is expected to exhibit a CAGR of 7.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Insulin is a natural glucose-lowering hormone that is invasively administered to diabetic patients for regulating their blood sugar levels. Insulin storage devices are adopted to maintain the efficacy of insulin and primarily include insulated kits, insulin cooling wallets or pouches, insulated cooler bags, and battery-operated storage devices. Insulin storage devices are widely adopted across clinics, hospitals, academic and research institutes, home-based medical setups, etc.
The high prevalence of diabetes due to hectic consumer lifestyles and unhealthy dietary patterns is primarily driving the market growth. The rising consumer awareness towards the use of insulin in diabetes preventive care is also augmenting the product demand. Moreover, the increasing healthcare expenditures have led to the emergence of advanced insulin storage devices offering high portability and secured handling. These smart insulin storage devices also provide additional features, such as temperature alert, dose reminders, expiry alert, and auto messaging. Moreover, the emergence of virtual training programs for diabetes management coupled with the increasing penetration of cloud-based health tracking solutions is also driving the market growth. Rapid innovations in the sector have also led to the introduction of biochemical sensors, laboratory-on-a-chip, and real-time monitoring technologies, that offer quick detection of insulin levels in the body. The emergence of smart wearables offering point-of-care testing with high diagnostic accuracy and prompt clinical evaluation is also catalyzing the demand for portable insulin storage devices. Furthermore, various technological advancements have led to the emergence of innovative digital diabetes management tools, including smart insulin patches, closed-loop insulin pumps, and advanced insulin pens.
IMARC Group provides an analysis of the key trends in each sub-segment of the global insulin storage devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type and patient type.
Breakup by Product Type:
Breakup by Patient Type:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Arkray Inc., COOL Sarl, Cooluli, DISONCARE, Medicool Inc., ReadyCare LLC, TAWA Outdoor (Xiamen Tawa Enterprise Co. Ltd.), Zhengzhou Dison Electric Co. Ltd. and Zhengzhou Olive Electronic Technology Co. Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Patient Type, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, China, Japan, India, South Korea, Australia, Indonesia, Thailand, Malaysia, Vietnam, Germany, France, United Kingdom, Italy, Spain, Russia, Brazil, Mexico, Argentina, Turkey, South Africa, Saudi Arabia, UAE|
|Companies Covered||Arkray Inc., COOL Sarl, Cooluli, DISONCARE, Medicool Inc., ReadyCare LLC, TAWA Outdoor (Xiamen Tawa Enterprise Co. Ltd.), Zhengzhou Dison Electric Co. Ltd. and Zhengzhou Olive Electronic Technology Co. Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at